hospital covid-19 information patient

Controversy over data in hydroxychloroquine COVID-19 study grows

Reading now: 692
www.cidrap.umn.edu

The editors of The Lancet yesterday issued a statement acknowledging the criticism of a recent study that concluded that the antimalaria drugs hydroxychloroquine and chloroquine did not benefit COVID-19 patients and were associated with higher risk of death and serious heart rhythm complications.The statement comes in response to a letter signed by more than 100 scientists and clinicians worldwide that raised questions about the data behind the large observational study.The Lancet said in its statement that important scientific questions had been raised about the data reported in the paper, and that an independent audit of the data commissioned by the authors is ongoing.The study, published in The Lancet on May 22, compared outcomes in

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA